PARSHALL B LYNNE
SEC Form 4 insider trading activity
PARSHALL B LYNNE has filed 9 SEC Form 4 filings (11 transaction rows) across 2 companies, including CYTK, IONS, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Sep 1, 2026.
On the most recent filing, PARSHALL B LYNNE is listed as Director at CYTOKINETICS INC. Inside the rolling window, PARSHALL B LYNNE reported no open-market purchases and 6 open-market sales totaling $2.2M in CYTK and IONS. The largest disclosed transaction in the window is a sale of 5,000 IONS shares on Feb 11, 2026, worth $414K.
Companies traded
Other insiders at CYTK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.2M
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has PARSHALL B LYNNE made?
PARSHALL B LYNNE has filed 9 SEC Form 4 filings (11 transaction rows) across 2 companies, including CYTK, IONS since 2025.
Which companies does PARSHALL B LYNNE trade?
PARSHALL B LYNNE has filed SEC Form 4 disclosures for 2 companies, including CYTK, IONS.
When was PARSHALL B LYNNE's most recent SEC Form 4 filing?
PARSHALL B LYNNE's most recent SEC Form 4 filing on Tracefour is dated Sep 1, 2026.
What is PARSHALL B LYNNE's total buy and sell value in the current window?
Inside the rolling retention window, PARSHALL B LYNNE bought $0 and sold $2.2M based on SEC Form 4 filings.
What was PARSHALL B LYNNE's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,000 IONS shares on 2026-02-11, worth $414K, per SEC Form 4 filings.